news, journals and articles from all over the world.
UTHealth Houston has enrolled the first patient in the Southeastern United States into a national Phase I/II clinical trial testing whether a neural cell therapy product can help inhibit the abnormal electrical activity that leads to an epileptic seizure.
Avian influenza A(H5N1) virus, which spread to cattle and infected 14 people this year, was detected using virome sequencing in the wastewater of 10 Texas cities by researchers at UTHealth Houston and Baylor College of Medicine.
Genetic variants linked to a rare form of bicuspid aortic valve disease that affects young adults and can lead to dangerous and potentially life-threatening aortic complications have been identified by researchers at UTHealth Houston.
The only Injury Control Research Center in Texas has been established by the Centers for Disease Control and Prevention at UTHealth Houston in partnership with Baylor College of Medicine.
A dangerous work environment and limited access to health care are related to higher death rates and negative health outcomes among Texas shrimpers in the Gulf of Mexico, according to a new study from UTHealth Houston.
Safety concerns for patients undergoing anesthesia who use glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which are medications approved for diabetes and weight management, were revealed in a UTHealth Houston study published today in JAMA Surgery.
Brian Dean, MBA, MPH, a highly respected health care executive with more than 25 years of experience leading health systems across the country, joins UTHealth Houston as executive vice president for health affairs, effective March 18.
Three commitments to improve food security, diet quality, and health outcomes for vulnerable communities, made by UTHealth Houston in partnership with local and national organizations, have been approved as part of the White House Challenge to end Hunger and Build Healthy Communities.
In recognition of its expertise in treating SCN2A-related neurological disorders, UTHealth Houston has been designated as the first SCN2A Multidisciplinary Center by the FamilieSCN2A Foundation, the largest global advocacy organization for the group of disorders.
Using the Nutrition Facts labels to make food choices is significantly associated with healthy eating among eighth and 11th grade students in Texas, although the proportion of students using nutrition labels to make their food choices is low, according to research from UTHealth Houston.
CATCH My Breath, an evidence-based vaping prevention program created by researchers from UTHealth Houston, is now being offered at New York City Public Schools, thanks to a partnership with CATCH Global Foundation and in collaboration with the New York Health Foundation and the New York City Department of Health and Mental Hygiene.
Michigan native Ruth Bischoff, 69, had tried everything – multiple spine surgeries, a radiofrequency ablation, acupuncture, a spinal cord stimulator, and more – but she couldn’t find any relief from the shooting pain in her lower back that prevented her from standing up straight and walking.
Alejandro Aballay, Pharm.D., Ph.D., a national leader in immune signaling and graduate education, has been named dean of the MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, effective Jan. 2, 2024.
Tissue-sparing treatments using focal therapy, aimed to avoid side effects like urinary incontinence, are becoming available for prostate cancer patients like Morton McPhail of Texas.
The implementation of artificial intelligence-powered large vessel occlusion (LVO) detection software for acute stroke triage can improve endovascular thrombectomy treatment times, according to new research from UTHealth Houston.
R.Á.P.I.D.O., a culturally relevant acronym created under the leadership of Jennifer Beauchamp, PhD, RN, at Cizik School of Nursing at UTHealth Houston to raise awareness of stroke signs in the Spanish-speaking Hispanic/Latino community and save lives, has been adopted by the American Stroke Association (ASA), the organization announced today.
Unruptured cerebral aneurysms of sizes and locations that require attention may be frequently missed in routine clinical care, but a machine learning algorithm could minimize missed care opportunities, according to a new study from UTHealth Houston.
An abstract unveiling a new mouse model for brain arteriovenous malformations (AVMs) developed by UTHealth Houston researchers has been selected for a poster presentation at the second annual National Institutes of Health (NIH) Investigator Meeting for Interoception Research in November.
After a rare view inside the world of professional sports and orthopedic medicine through a clinical rotation with the Houston Texans this summer, Analisa Narro, a fourth-year student with McGovern Medical School at UTHealth Houston, brought back key lessons from the enriching experience.
Prior vaccination against tetanus and diphtheria, with or without pertussis (Tdap/Td); herpes zoster (HZ), better known as shingles; and pneumococcus are all associated with a reduced risk for developing Alzheimer’s disease, according to new research from UTHealth Houston.
A five-year, $3.1 million grant to study preventive strategies for sudden unexpected death in epilepsy (SUDEP) has been awarded to UTHealth Houston by the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke.
Despite having worse stroke symptoms and living within comparable distances to comprehensive stroke centers, women with large vessel occlusion acute ischemic stroke are less likely to be routed to the centers compared to men, according to a new study from UTHealth Houston.
The FDA is being asked to investigate the popular energy drink, PRIME, which contains elevated levels of caffeine equivalent to 6 cans of coke. John Higgins, MD, energy drink researcher and cardiologist with UTHealth Houston is availble for interviews to discuss the…
Versil Joyles-Stapleton, 76, can’t seem to slow herself down — a drastic change to how she lived her life just 2 years ago.
The FDA has granted Priority Review to the anti-Alzheimer’s drug Leqembi for the traditional approval application, with required action from the agency by July 6, 2023. Paul E. Schulz, MD, professor of neurology and director of the Neurocognitive Disorders Center with McGovern…
Children and teenagers who volunteer tend to flourish mentally and physically, according to a new study from UTHealth Houston.
Nearly $13 million in federal grant funds to study treatments for traumatic brain injury, which kills an average of 190 people and hospitalizes another 600 in the U.S. every day, has been awarded to UTHealth Houston by the Department of Defense’s Office of Congressionally Directed Medical Research Programs (CDMRP).
UTHealth Houston pediatric dentists are now part of the Integrated Health Clinic, a program of Harris County Resources for Children and Adults, by providing comprehensive medical, dental, and behavioral health care for children in Harris County who are involved or under the care of Child Protective Services.
The drug valbenazine statistically improves chorea, a movement disorder commonly associated with Huntington’s disease, when compared to a placebo, according to a recent international study led by UTHealth Houston researcher Erin Furr Stimming, MD, who served as principal investigator on behalf of the KINECT-HD Huntington Study Group.
When a person reads a sentence, two distinct networks in the brain are activated, working together to integrate the meanings of the individual words to obtain more complex, higher-order meaning, according to a study at UTHealth Houston.
The presence of a misfolded alpha-synuclein protein can be used to determine if people have Parkinson’s disease, according to a new study using technology developed by a researcher at UTHealth Houston. This biomarker could pave the way for the development of better diagnostic tools and new treatment options for the disease.
The new UTHealth Houston School of Behavioral Health Sciences has been approved by the Texas Higher Education Coordinating Board and unanimously by The University of Texas System Board of Regents, moving the university closer to establishing a seventh school.
Paul E. Schulz, MD, neurologist with UTHealth Houston and Memorial Hermann, is available over the next few days to comment on recent news that the Veterans Health Administration will provide coverage for Leqembi, which recently received accelerated approval from the…
Prenatal exposure to an anti-nausea drug commonly used in the 1960s and 1970s has been shown to increase risk of colorectal cancer in adult offspring, according to a study by researchers at UTHealth Houston.
Seizures can be predicted more than 30 minutes before onset in patients with temporal lobe epilepsy, opening the door to a therapy using electrodes that could be activated to prevent seizures from happening, according to new research from UTHealth Houston.
The evidence does not support the common belief that indwelling catheters cause more urinary tract infections (UTIs) than intermittent catheterization, according to a systematic review of bladder management and infection risk from UTHealth Houston.
Breakthrough COVID-19 infections after vaccination occurred in 7.5% of Texans surveyed and were linked to Hispanic ethnicity, larger household size, rural versus urban living, type of vaccination, and multiple comorbidities, according to findings from UTHealth Houston School of Public Health published today in the Journal of Infectious Diseases.
Deanna Hoelscher, PhD, John P. McGovern Professor in Health Promotion and campus dean of UTHealth Houston School of Public Health in Austin, has been appointed to the 2025 Dietary Guidelines Advisory Committee. The Committee will be tasked with reviewing the current body of science on key nutrition topics and developing a scientific report that includes its independent assessment of the evidence and recommendations for the U.S. Department of Health and Human Services and U.S. Food and Drug Administration as they develop the Dietary Guidelines for Americans (the Guidelines).
School garden-based interventions can improve metabolic parameters such as blood sugar and cholesterol in children, according to a new study from UTHealth Houston.
After hundreds of thousands of miles and 20 years of service, UTHealth Houston School of Dentistry has a new set of wheels for its Mobile Dental Van program to continue providing care to underserved communities.
A five-year, nearly $3.5 million grant to study the mechanisms of brain receptors involved in neurological disorders such as learning disabilities has been awarded to Vasanthi Jayaraman, PhD, of UTHealth Houston by the National Institutes of Health.
A new method for determining whether patients with heart disease need coronary stents or bypass surgery is more effective than the angiogram, which is currently used, according to research from UTHealth Houston Heart & Vascular.
Mechanisms involved in the rapid, severe progression of fibrosis in the lung tissues of COVID-19 patients, a potentially fatal complication of the virus that damages and scars the lungs, have been uncovered by researchers led by UTHealth Houston.
Older adults residing in assisted living facilities and quarantined to their rooms during the height of the COVID-19 pandemic lost significant weight, according to gerontology care providers and researchers from McGovern Medical School at UTHealth Houston.
Research shows that incidences of Kaposi’s sarcoma among people living with HIV have fallen significantly over the past two decades, but a new evaluation of data led by researchers at UTHealth Houston highlights a significant disparity among one particular demographic – young Black men in the American South.
In acknowledgment of her research advancing the field of cardiovascular science, UTHealth Houston’s Louise McCullough, MD, PhD, has been honored with the 2022 American Heart Association Basic Research Prize.
A substantial proportion of ethnically diverse children from low-resource backgrounds with severe COVID-19 illness are reporting long-term complications from the virus, according to research from UTHealth Houston.
A method that combines case investigation data from local health departments and hospitalizations records from local institutions allows for the objective detection of new waves of infection during a pandemic, according to research from UTHealth Houston.
Populations in U.S. counties defined as more vulnerable based on social factors including socioeconomic status and racial/ethnic minority status were significantly less likely to receive timely breast, cervical, and colorectal cancer screenings, according to research from UTHealth Houston.
Imagine having to drink a solution of cornstarch and water every four hours to survive, and that missing a dose, even by 15 minutes, could lead to seizures and death. This is the reality for Rebecca Tarrence, who has glycogen storage disease type 1a (GSDIa), a rare genetic disease caused by the presence of two genetic changes on the same gene affecting glucose production.
English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
Urdu